Skip to main content

Advertisement

SpringerLink
Log in

Optimal management of non-functioning pituitary adenomas

  • Mini Review
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Transsphenoidal surgery is the treatment of choice for large non-functioning pituitary adenomas (NFPA) and symptomatic patients. The therapeutic strategies for the management of NFPA after surgery, i.e., watchful waiting, irradiation, or medical therapy have not been compared by randomized controlled trials. Slow re-growth is common, but the natural history of untreated tumors is variable. Conservative follow-up is associated with progression rates of over 40 %. Radiation is highly effective in preventing residual tumor growth, but has serious long-term side effects. Finally, no medications are currently approved for the treatment of NFPA. In this review, we present our view of the optimal management of these tumors, which includes risk stratification for the identification of high-risk patients suitable for active intervention, leaving low-risk patients for careful monitoring.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. M. Al-Shraim, S.L. Asa, The 2004 World Health Organization classification of pituitary tumors: what is new? Acta Neuropathol. 111, 1–7 (2006)

    Article  PubMed  Google Scholar 

  2. W. Saeger, D.K. Lüdecke, M. Buchfelder, R. Fahlbusch, H.J. Quabbe, S. Petersenn, Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur. J. Endocrinol. 156, 203–216 (2007)

    Article  CAS  PubMed  Google Scholar 

  3. S.L. Asa, Practical pituitary pathology. What does the pathologist need to know? Arch. Pathol. Lab. Med. 132, 1231–1240 (2008)

    PubMed  Google Scholar 

  4. H. Nishioka, M. Ozgur, S.L. Asa, N. Inoshita, N. Fukuhara, K. Horiguchi, S. Yamada, The crucial role of pituitary transcription factors in the accurate classification of hormone-negative nonfunctioning pituitary adenomas. Endocrine Society Meeting 2014, OR09-2

  5. Y. Greenman, N. Stern, Non-functioning pituitary adenomas. Best Pract. Res. Clin. Endocrinol. Metab. 23, 625–638 (2009)

    Article  CAS  PubMed  Google Scholar 

  6. M. Losa, P. Mortini, R. Barzaghi, P. Ribotto, M.R. Terreni, S.B. Marzoli, S. Pieralli, M. Giovanelli, Early results of surgery in patients with nonfunctioning pituitary adenomas and analysis of the risk of tumor recurrence. J. Neurosurg. 108, 525–532 (2008)

    Article  PubMed  Google Scholar 

  7. O.M. Dekkers, A.M. Pereira, J.H.C. Roelfsema, J.H. Voormolen, K.J. Neelis, M.A. Schroijen, J.W. Smit, J.A. Romijn, Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J. Clin. Endocrinol. Metab. 91, 1796–1801 (2006)

    Article  CAS  PubMed  Google Scholar 

  8. P. Nomikos, C. Ladar, R. Fahlbusch, M. Buchfelder, Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas—a study on 721 patients. Acta Neurochir. 146, 27–35 (2004)

    Article  CAS  PubMed  Google Scholar 

  9. Y. Greenman, K. Tordjman, E. Kisch, N. Razon, G. Ouaknine, N. Stern, Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas. J. Clin. Endocrinol. Metab. 80, 1577–1583 (1995)

    CAS  PubMed  Google Scholar 

  10. S.M. Webb, M. Rigla, A. Wägner, B. Oliver, F. Bartumeus, Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J. Clin. Endocrinol. Metab. 84, 3696–3700 (1999)

    Article  CAS  PubMed  Google Scholar 

  11. R. Reddy, S. Cudlip, J.V. Byrne, N. Karavitaki, J.A. Wass, Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma? Eur. J. Endocrinol. 165, 739–744 (2011)

    Article  CAS  PubMed  Google Scholar 

  12. J. Honneger, U. Ernemann, T. Psaras, B. Will, Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study. Acta Neurochir. 149, 21–29 (2007)

    Article  Google Scholar 

  13. M. Molitch, Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol. Clin. Metab. North Am. 37, 151–171 (2008)

    Article  Google Scholar 

  14. N. Karavitaki, K. Collison, J. Halliday, J.V. Byrne, P. Price, S. Cudlip, J.A. Wass, What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin. Endocrinol. 67, 938–943 (2007)

    Article  CAS  Google Scholar 

  15. J. Feldkamp, R. Santen, E. Harms, A. Aulich, U. Mödder, W.A. Scherbaum, Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas-results of a prospective study. Clin. Endocrinol. 51, 109–113 (1999)

    Article  CAS  Google Scholar 

  16. K. Arita, A. Tominaga, K. Sugiyama, K. Eguchi, K. Iida, M. Sumida, K. Migita, K. Kurisu, Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J. Neurosurg. 104, 884–891 (2006)

    Article  PubMed  Google Scholar 

  17. O.M. Dekkers, S. Hammer, R.J.W. de Keizer, F. Roelfsema, P.J. Schutte, J.W. Smit, J.A. Romijn, A.M. Pereira, The natural course of non-functioning pituitary macroadenomas. Eur. J. Endocrinol. 156, 217–224 (2007)

    Article  CAS  PubMed  Google Scholar 

  18. Y. Greenman, G. Ouaknine, I. Veshchev, I.I. Reider-Groswasser, Y. Segev, N. Stern, Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin. Endocrinol. 58, 763–769 (2003)

    Article  CAS  Google Scholar 

  19. E. Ferrante, M. Ferraroni, T. Castrignano, L. Menicatti, M. Anagni, G. Reimondo, P. Del Monte, D. Bernascon, P. Loli, M. Faustini-Fustini, G. Borretta, M. Terzolo, M. Losa, A. Morabito, A. Spada, P. Beck-Peccoz, A.G. Lania, Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur. J. Endocrinol. 155, 823–829 (2006)

    Article  CAS  PubMed  Google Scholar 

  20. P. Park, W. Chandler, A. Barkan, J.J. Orrego, J.A. Cowan, K.A. Griffith, C. Tsien, The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 55, 100–106 (2004)

    Article  PubMed  Google Scholar 

  21. E.P. O’Sullivan, C. Woods, N. Glynn, L.A. Behan, R. Crowley, P. O’Kelly, D. Smith, C.J. Thompson, A. Agha, The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas. Clin. Endocrinol. 71, 709–714 (2009)

    Article  Google Scholar 

  22. N.J.L. Gittoes, A.S. Bates, W. Tse, B. Bullivant, M.C. Sheppard, R.N. Clayton, P.M. Stewart, Radiotherapy for non-functioning pituitary tumours. Clin. Endocrinol. 48, 331–337 (1998)

    Article  CAS  Google Scholar 

  23. A.A. Kanner, B.W. Corn, Y. Greenman, Radiotherapy of nonfunctioning and gonadotroph adenomas. Pituitary 12, 15–22 (2009)

    Article  PubMed  Google Scholar 

  24. E.F. Chang, G. Zada, S. Kim, K.R. Lamborn, A. Quinones-Hinojosa, J.B. Tyrrell, C.B. Wilson, S. Kunwar, Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J. Neurosurg. 108, 736–745 (2008)

    Article  PubMed  Google Scholar 

  25. S. Brochier, F. Galland, M. Kujas, F. Parker, S. Gaillard, C. Raftopoulos, J. Young, O. Alexopoulou, D. Maiter, P. Chanson, Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. Eur. J. Endocrinol. 163, 193–200 (2010)

    Article  CAS  PubMed  Google Scholar 

  26. Y. Chen, C.D. Wang, Z.P. Su, Y.X. Chen, L. Cai, Q.C. Zhuge, Z.B. Wu, Natural history of postoperative nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Neuroendocrinology 96, 333–342 (2012)

    Article  CAS  PubMed  Google Scholar 

  27. K.J. Bradley, J.A. Wass, H.E. Turner, Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumors but do not recur more frequently. Clin. Endocrinol. 58, 59–64 (2003)

    Article  CAS  Google Scholar 

  28. D. Erickson, B. Scheithauer, J. Atkinson, E. Horvath, K. Kovacs, R.V. Lloyd, W.F. Young Jr, Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience. Clin. Endocrinol. 71, 92–99 (2009)

    Article  CAS  Google Scholar 

  29. G. Kontogeorgos, Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83, 179–188 (2006)

    Article  CAS  PubMed  Google Scholar 

  30. K. Thapar, K. Kovacs, B. Scheithauer, L. Stefaneanu, E. Horvath, P.J. Pernicone, D. Murray, E.R. Laws Jr, Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38, 99–107 (1996)

    Article  CAS  PubMed  Google Scholar 

  31. L. Mastronardi, A. Guiducci, C. Spera, F. Puzzilli, F. Liberati, G. Maira, Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. J. Clin. Pathol. 52, 107–111 (1999)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. G. Widhalm, S. Wolfsberger, M. Preusser, I. Fischer, A. Woehrer, J. Wunderer, J.A. Hainfellner, E. Knosp, Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression. J. Neurosurg. 111, 563–571 (2009)

    Article  PubMed  Google Scholar 

  33. C. Ramírez, S. Cheng, G. Vargas, S.L. Asa, S. Ezzat, B. González, L. Cabrera, G. Guinto, M. Mercado, Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study. J. Clin. Endocrinol. Metab. 97, 1745–1751 (2012)

    Article  PubMed  Google Scholar 

  34. M. Losa, A. Franzin, F. Mangili, M.R. Terreni, R. Barzaghi, F. Veglia, P. Mortini, M. Giovanelli, Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long term follow-up studies. Neurosurgery 47, 1313–1319 (2000)

    Article  CAS  PubMed  Google Scholar 

  35. S. Dubois, S. Guyetant, P. Menei, P. Rodien, F. Illouz, B. Vielle, V. Rohmer, Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery. Eur. J. Endocrinol. 157, 141–147 (2007)

    Article  CAS  PubMed  Google Scholar 

  36. J. Honegger, C. Prettin, F. Feuerhake, M. Petrick, J. Schulte-Mönting, M. Reincke, Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness. J. Neurosurg. 99, 674–679 (2003)

    Article  PubMed  Google Scholar 

  37. R. Gejman, B. Swearingen, E.T. Hedley-Whyte, Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum. Pathol. 38, 758–766 (2008)

    Article  Google Scholar 

  38. K.H. Darzy, S.M. Shalet, Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 8, 203–211 (2005)

    Article  PubMed  Google Scholar 

  39. G. Minniti, D. Traish, S. Ashley, A. Gonsalves, M. Brada, Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenomas: update after an additional 10 years. J. Clin. Endocrinol. Metab. 90, 800–804 (2005)

    Article  CAS  PubMed  Google Scholar 

  40. E.M. Erfurth, B. Bulow, G. Svahn-Tapper, B. Norrving, K. Odh, Z. Mikoczy, J. Björk, L. Hagmar, Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors. J. Clin. Endocrinol. Metab. 87, 4892–4899 (2002)

    Article  CAS  PubMed  Google Scholar 

  41. J.P. Sheehan, R.M. Starke, D. Mathieu, B. Young, P.K. Sneed, V.L. Chiang, J.Y. Lee, H. Kano, K.J. Park, A. Niranjan, D. Kondziolka, G.H. Barnett, S. Rush, J.G. Golfinos, L.D. Lunsford, Gamma knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J. Neurosurg. 119, 446–456 (2013)

    Article  PubMed  Google Scholar 

  42. Y. Chen, Z.F. Li, F.X. Zhang, J.X. Li, L. Cai, Q.C. Zhuge, Z.B. Wu, Gamma knife surgery for patients with volumetric classification of nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Eur. J. Endocrinol. 169, 487–495 (2013)

    Article  CAS  PubMed  Google Scholar 

  43. D. Van Schaadenburg, F. Roefselma, A.V. Seters, G.J. Vielvoye, Bromocriptine therapy for non-functioning pituitary adenoma. Clin. Endocrinol. 30, 475–484 (1989)

    Article  Google Scholar 

  44. A. Colao, C. Di Somma, R. Pivonello, A. Faggiano, G. Lombardi, S. Savastano, Medical therapy for clinically non-functioning pituitary adenomas. Endocr. Relat. Cancer 15, 905–915 (2008)

    Article  CAS  PubMed  Google Scholar 

  45. Z. Su, C. Wang, J. Wu, X. Jiang, Y. Chen, Y. Chen, W. Zheng, Q. Zhuge, Z. Wu, Y. Zeng, Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas. Neurol. Sci. 33, 275–279 (2012)

    Article  PubMed  Google Scholar 

  46. Y. Greenman, K. Tordjman, E. Osher, I. Veshchev, G. Shenkerman, I.I. Reider-Groswasser, Y. Segev, G. Ouaknine, N. Stern, Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth. Clin. Endocrinol. 63, 39–44 (2005)

    Article  CAS  Google Scholar 

  47. T. Lohmann, C. Trantakis, M. Biesold, S. Prothmann, S. Guenzel, R. Schober, R. Paschke, Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline. Pituitary 4, 173–178 (2001)

    Article  CAS  PubMed  Google Scholar 

  48. R. Pivonello, C. Matrone, M. Filippela, L.M. Cavallo, C. Di Somma, P. Cappabianca, A. Colao, L. Annunziato, G. Lombardi, Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. J. Clin. Endocrinol. Metab. 89, 1674–1683 (2004)

    Article  CAS  PubMed  Google Scholar 

  49. W.W. de Herder, A.E. Reijs, R.A. Feelders, M.O. van Aken, E.P. Krenning, H.L. Tanghe, A.J. van der Lely, D.J. Kwekkeboom, Dopamine agonist therapy of clinically non-functioning pituitary macroadenomas. Is there a role for 123I-epidepride dopamine D2 receptor imaging? Eur. J. Endocrinol. 155, 717–723 (2006)

    Article  PubMed  Google Scholar 

  50. E.C. Garcia, L.A. Naves, A.O. Silva, L.F. de Castro, L.A. Casulari, M.F. Azevedo, Short-term treatment with cabergoline can lead to tumor shrinkage in patients with nonfunctioning pituitary adenomas. Pituitary 16, 189–194 (2013)

    Article  CAS  PubMed  Google Scholar 

  51. R. Zanettini, A. Antonini, G. Gatto, R. Gentile, S. Tesei, G. Pezzoli, Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. N. Engl. J. Med. 356, 39–46 (2007)

    Article  CAS  PubMed  Google Scholar 

  52. P. Lancellotti, E. Livadariu, M. Markov, A.F. Daly, M.C. Burlacu, D. Betea, L. Pierard, A. Beckers, Cabergoline and the risk of valvular lesions in endocrine disease. Eur. J. Endocrinol. 159, 1–5 (2008)

    Article  CAS  PubMed  Google Scholar 

  53. M.C. Zatelli, D. Piccin, C. Vignalli, F. Tagliati, M.R. Ambrosio, M. Bondanelli, V. Cimino, A. Bianchi, H.A. Schmid, M. Scanarini, A. Pontecorvi, L. De Marinis, G. Maira, E.C. degli Uberti, Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. Endocr. Relat. Cancer 14, 91–102 (2007)

    Article  CAS  PubMed  Google Scholar 

  54. Y. Greenman, S. Melmed, Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J. Clin. Endocrinol. Metab. 79, 724–729 (1994)

    CAS  PubMed  Google Scholar 

  55. G. Raverot, N. Sturm, F. de Fraipont, M. Muller, S. Salenave, P. Caron, O. Chabre, P. Chanson, C. Cortet-Rudelli, R. Assaker, H. Dufour, S. Gaillard, P. François, E. Jouanneau, J.G. Passagia, M. Bernier, A. Cornélius, D. Figarella-Branger, J. Trouillas, F. Borson-Chazot, T. Brue, Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. J. Clin. Endocrinol. Metab. 95, 4592–4599 (2010)

    Article  CAS  PubMed  Google Scholar 

  56. A.I. McCormack, J.A. Wass, A.B. Grossman, Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status. Eur. J. Clin. Invest. 41, 1133–1148 (2011)

    Article  CAS  PubMed  Google Scholar 

  57. G. Raverot, F. Castinetti, E. Jouanneau, I. Morange, D. Figarella-Branger, H. Dufour, J. Trouillas, T. Brue, Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment. Clin. Endocrinol. 76, 769–775 (2012)

    Article  CAS  Google Scholar 

  58. T. Hirohata, K. Asano, Y. Ogawa, S. Takano, K. Amano, O. Isozaki, Y. Iwai, K. Sakata, N. Fukuhara, H. Nishioka, S. Yamada, S. Fujio, K. Arita, K. Takano, A. Tominaga, N. Hizuka, H. Ikeda, R.Y. Osamura, S. Tahara, Y. Ishii, T. Kawamata, A. Shimatsu, A. Teramoto, A. Matsuno, DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumors. J. Clin. Endocrinol. Metab. 98, 1130–1136 (2013)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv-Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Yona Greenman & Naftali Stern

Authors
  1. Yona Greenman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naftali Stern
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yona Greenman.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Greenman, Y., Stern, N. Optimal management of non-functioning pituitary adenomas. Endocrine 50, 51–55 (2015). https://doi.org/10.1007/s12020-015-0685-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-015-0685-8

Keywords

Search

Navigation